Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds

Published:2021 Issue:8 Volume:8 Page:1983-1996
ISSN:2052-1553
Container-title:Inorganic Chemistry Frontiers
language:en
Short-container-title:Inorg. Chem. Front.

Author:

Teixeira Ricardo G.¹²³⁴⁵,Belisario Dimas C.⁶⁷⁸⁹,Fontrodona Xavier¹⁰¹¹¹²¹³,Romero Isabel¹⁰¹¹¹²¹³^ORCID,Tomaz Ana Isabel¹²³⁴⁵,Garcia M. Helena¹²³⁴⁵,Riganti Chiara⁶⁷⁸⁹,Valente Andreia¹²³⁴⁵^ORCID

Affiliation:

1. Centro de Química Estrutural and Departamento de Química e Bioquímica

2. Faculdade de Ciências

3. Universidade de Lisboa

4. 1749-016 Lisboa

5. Portugal

6. Department of Oncology

7. University of Torino

8. Torino

9. Italy

10. Departament de Química and Serveis Tècnics de Recerca

11. Universitat de Girona

12. E-17003 Girona

13. Spain

Abstract

Ru compounds exhibit collateral sensitivity in cisplatin-resistant NSCLC and increase cisplatin activity by inhibiting efflux pumps.

Funder

Fundação para a Ciência e a Tecnologia

Associazione Italiana per la Ricerca sul Cancro

European Cooperation in Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/QI/D0QI01344G

Reference46 articles.

1. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

2. Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

3. Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes

4. Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms

5. Selection and characterization of a human ovarian cancer cell line resistant to auranofin

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lead to hit ruthenium-cyclopentadienyl anticancer compounds: Cytotoxicity against breast cancer cells, metabolic stability and metabolite profiling;Journal of Inorganic Biochemistry;2024-02

2. Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies;European Journal of Medicinal Chemistry;2023-12

3. Fighting Multidrug Resistance with Ruthenium–Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition;Journal of Medicinal Chemistry;2023-08-24

4. Shifting KRAS hotspot mutations inhibition paradigm in colorectal cancer;2023-08-13

5. Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands;Organometallics;2023-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3